Cigna Corp. Stock
Cigna Corp. Stock
Cigna Corp. gained 0.470% compared to yesterday.
The stock is an absolute favorite of our community with 42 Buy predictions and no Sell predictions.
With a target price of 336 € there is a positive potential of 43.59% for Cigna Corp. compared to the current price of 234.0 €.
Pros and Cons of Cigna Corp. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cigna Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cigna Corp. | 0.470% | 2.699% | 0.150% | -13.430% | -11.565% | -27.329% | 32.955% |
| Centene Corp. | 1.900% | 5.727% | 11.396% | -37.195% | -39.499% | -57.813% | -30.525% |
| Humana Inc. | 0.790% | 3.252% | 10.169% | -12.279% | -5.810% | -54.553% | -29.444% |
| UnitedHealth Group Inc. | 1.590% | 2.535% | -0.478% | -40.897% | -40.064% | -43.795% | 4.711% |
Comments
Cigna Group (NYSE:CI) had its price target lowered by analysts at Robert W. Baird from $372.00 to $315.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE:CI) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Show more
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE:CI) had its "buy" rating reaffirmed by analysts at Guggenheim.
Show more
Ratings data for CI provided by MarketBeat
News
Cigna (CI) Q2 Revenue Jumps 11%
Cigna Group (NYSE:CI), a global health services company offering integrated medical, pharmacy, and specialty care solutions, released its second-quarter earnings on July 31, 2025. The company
